Fund Profiles' New Top Picks: Buy the Crashed Giant
Summary by Dagens Industri
1 Articles
1 Articles
All
Left
Center
Right
Two new companies have taken their place in Carnegie's Strategy Fund – a pharmaceutical company facing headwinds and an engineering giant in transition. The managers' assessment: The market is turning a blind eye to short-term concerns and missing out on long-term value.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium